tetano
Editor, Senior Moderator
J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149.
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
Ahn JY[SUP]#[/SUP][SUP]1[/SUP], Sohn Y[SUP]#[/SUP][SUP]1[/SUP], Lee SH[SUP]1[/SUP], Cho Y[SUP]1[/SUP], Hyun JH[SUP]1[/SUP], Baek YJ[SUP]1[/SUP], Jeong SJ[SUP]1[/SUP], Kim JH[SUP]1[/SUP], Ku NS[SUP]1[/SUP], Yeom JS[SUP]1[/SUP], Roh J[SUP]2[/SUP], Ahn MY[SUP]3[/SUP], Chin BS[SUP]4[/SUP], Kim YS[SUP]1[/SUP], Lee H[SUP]2[/SUP], Yong D[SUP]2[/SUP], Kim HO[SUP]2[/SUP], Kim S[SUP]5[/SUP], Choi JY[SUP]6[/SUP].
Author information
Abstract
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.
? 2020 The Korean Academy of Medical Sciences.
KEYWORDS:
COVID-19; Convalescent Plasma; Coronavirus; SARS-CoV-2; Treatment
PMID:32281317DOI:10.3346/jkms.2020.35.e149
Free full text
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
Ahn JY[SUP]#[/SUP][SUP]1[/SUP], Sohn Y[SUP]#[/SUP][SUP]1[/SUP], Lee SH[SUP]1[/SUP], Cho Y[SUP]1[/SUP], Hyun JH[SUP]1[/SUP], Baek YJ[SUP]1[/SUP], Jeong SJ[SUP]1[/SUP], Kim JH[SUP]1[/SUP], Ku NS[SUP]1[/SUP], Yeom JS[SUP]1[/SUP], Roh J[SUP]2[/SUP], Ahn MY[SUP]3[/SUP], Chin BS[SUP]4[/SUP], Kim YS[SUP]1[/SUP], Lee H[SUP]2[/SUP], Yong D[SUP]2[/SUP], Kim HO[SUP]2[/SUP], Kim S[SUP]5[/SUP], Choi JY[SUP]6[/SUP].
Author information
Abstract
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.
? 2020 The Korean Academy of Medical Sciences.
KEYWORDS:
COVID-19; Convalescent Plasma; Coronavirus; SARS-CoV-2; Treatment
PMID:32281317DOI:10.3346/jkms.2020.35.e149
Free full text